Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Mdaw94on Apr 20, 2019 10:49am
93 Views
Post# 29650776

RE:RE:RE:RE:RE:Wow

RE:RE:RE:RE:RE:Wow
Homestretch4me wrote: You Aurora investors really are uneducated when it comes to the cannabis space. Canopy is heads and tails ahead of Aurora when it comes to real medical cannabis. Canopy has a boatload of patents approved and pending. Canopy also has some phase IIB medical trials in progress. Be careful because Aurora might get shut out of the real medical market once DIN (that's drug identification numbers for you Aurora investors) numbers start getting issued after real medical trials are finished. I encourage all of you to research the number of patents and clinical trials that each company has underway. I think you will be very disappointed in your management team once you find out the truth. Right now every cannabis company can sell what they claim to be medical cannabis but when the clinical trials are finished, that will no longer be the case. Companies will need DIN numbers in order to make medical claims. Aurora is light years behind.
12CenterLine wrote: From what I can see is that you are very near sighted. You need to understand that the cannabis infused beverage industry will be a fad. Sure there is opportunity to make money but that isn't where the real market is. It is and has always been on the medical side. Better margins and the Pharma application for cannabis will trump the beverage industry hands down. Our demographic is getting older and the baby boomers are looking for now, more than ever,non traditional ways to cure their ailments.


Homestretch4me wrote: That's exactly my point. Canopy's management was able to broker a 5 billion dollar deal on their own while Aurora's management has had to ask for help. It is tough to get a partner when you have had reckless dilution and have over a billion shares. Let's see what Nelson can broker that your management team couldn't. Have you asked yourself why other smaller companies like Hexo and Cronos were able to get partnerships/deals? Why did a lot of fortune 500 companies pass on Aurora?
mozzarella wrote: $Nelson Petlz and his connections$ is who you need to chat with not a message board concerning your silly antics .... you have no ideal do you? 


Homestretch4me wrote:
320,000,000 shares is what it would cost Aurora to do a deal like Canopy just did. You guys are now stuck spinning your wheels because you have no cash.

 

 

 




Medical marijuana? Canopy? are they going to sell this from converted tomato farms lol. The German government would not even consider them. Something to do with EU GMP I guess. Crop loss and tomato bugs won’t help with all there “DIN” testing would it? I don’t know I don’t smoke tomato bugs. The only deal canopy did was sell out to the US even before legalization. Now with this Acreage deal 300 mil for the “rights” then 3.5 billion in a mostly shares deal( there words) fully deleted they are on there way to a billion shares outstanding as well . Have you done any DD on Acreage? You really should . 41 percent premium on top of overvaluation? Ouch that’s a lotta good will to some shareholders. But not you. I suspect Canapys stock to continue to average down imo. But hopefully not . I would like to see the whole industry do well
Bullboard Posts